Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cadoz

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|August 1, 1986
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccinesC O Tacket, C Ferreccio, J B Robbins, et al.
Developments in Biological Standardization|January 1, 1995
The safety and use of canarypox vectored vaccinesS A Plotkin, M Cadoz, B Meignier, et al.
FEMS Immunology and Medical Microbiology|March 27, 2001
Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic onesV Sanchez, S Gimenez, J Haensler, et al.
The Journal of Infectious Diseases|March 23, 2001
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjectsK Berencsi, Z Gyulai, E Gönczöl, et al.
Research in Virology|September 1, 1991
Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central AfricaM C Georges-Courbot, J Monges, M R Siopathis, et al.
The New England Journal of Medicine|October 29, 1987
Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary reportI L Acharya, C U Lowe, R Thapa, et al.
Gut|August 13, 2004
Challenge model for Helicobacter pylori infection in human volunteersD Y Graham, A R Opekun, M S Osato, et al.
Vaccine|November 19, 1997
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in SenegalF Simondon, M P Preziosi, A Yam, et al.
The Journal of Infectious Diseases|August 7, 1999
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)S P Adler, S A Plotkin, E Gonczol, et al.
Lancet (London, England)|February 16, 1980
Pneumococcal serotypes in West AfricaB M Greenwood, M Hassan-King, G Onyemelukwe, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|August 1, 1986
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccinesC O Tacket, C Ferreccio, J B Robbins, et al.
Developments in Biological Standardization|January 1, 1995
The safety and use of canarypox vectored vaccinesS A Plotkin, M Cadoz, B Meignier, et al.
FEMS Immunology and Medical Microbiology|March 27, 2001
Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic onesV Sanchez, S Gimenez, J Haensler, et al.
The Journal of Infectious Diseases|March 23, 2001
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjectsK Berencsi, Z Gyulai, E Gönczöl, et al.
Research in Virology|September 1, 1991
Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central AfricaM C Georges-Courbot, J Monges, M R Siopathis, et al.
The New England Journal of Medicine|October 29, 1987
Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary reportI L Acharya, C U Lowe, R Thapa, et al.
Gut|August 13, 2004
Challenge model for Helicobacter pylori infection in human volunteersD Y Graham, A R Opekun, M S Osato, et al.
Vaccine|November 19, 1997
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in SenegalF Simondon, M P Preziosi, A Yam, et al.
The Journal of Infectious Diseases|August 7, 1999
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)S P Adler, S A Plotkin, E Gonczol, et al.
Lancet (London, England)|February 16, 1980
Pneumococcal serotypes in West AfricaB M Greenwood, M Hassan-King, G Onyemelukwe, et al.
Pageof 5